InvestSMART

Echo IQ Limited (ASX: EIQ) - Announcements

Current share price for EIQ : $1.500 0.09 (5.66%)+

ASX company news and announcements for Echo IQ Limited (EIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Echo IQ Limited (EIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Echo IQ Limited (EIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Echo IQ Limited (EIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,107 Notification regarding unquoted securities - EIQ 15 Jul 2026 6:32PM $1.570 $1.500 fallen by 4.46%
$1,107 Cleansing Notice 15 Jul 2026 6:09PM $1.570 $1.500 fallen by 4.46%
$1,107 Application for quotation of securities - EIQ 15 Jul 2026 5:59PM $1.570 $1.500 fallen by 4.46%
$1,107 Ceasing to be a substantial holder 10 Jul 2026 5:25PM $1.660 $1.500 fallen by 9.64%
$1,107 Cleansing Notice 7 Jul 2026 9:40AM $1.630 $1.500 fallen by 7.98%
$1,107 Application for quotation of securities - EIQ 7 Jul 2026 9:37AM $1.630 $1.500 fallen by 7.98%
$1,107 Exclusive Imaging Dataset Strengthens AI Competitive Moat 2 Jul 2026 8:51AM $1.620 $1.500 fallen by 7.41%
$1,107 Proposed issue of securities - EIQ 1 Jul 2026 9:16AM $1.590 $1.500 fallen by 5.66%
$1,107 Echo IQ Raises A$110m via Institutional Placement 1 Jul 2026 9:15AM $1.590 $1.500 fallen by 5.66%
$1,107 Trading Halt 29 Jun 2026 9:16AM $1.590 $1.500 fallen by 5.66%
$1,107 Proposed issue of securities - EIQ 25 Jun 2026 10:47AM $1.640 $1.500 fallen by 8.54%
$1,107 Binding HOA secured with Pro Medicus Limited 25 Jun 2026 8:51AM $1.240 $1.500 risen by 20.97%
$1,107 Leadership team and clinical advisory network strengthened 23 Jun 2026 8:13AM $1.230 $1.500 risen by 21.95%
$1,107 Updated Securities Trading Policy 19 Jun 2026 2:26PM $1.210 $1.500 risen by 23.97%
$1,107 Research collaboration secured with Mayo Clinic 12 Jun 2026 9:02AM $1.185 $1.500 risen by 26.58%
$1,107 Change of Address 9 Jun 2026 6:39PM $1.270 $1.500 risen by 18.11%
$1,107 Notification regarding unquoted securities - EIQ 26 May 2026 11:30AM $1.290 $1.500 risen by 16.28%
$1,107 $762k R&D Tax Incentive Received 26 May 2026 8:54AM $1.325 $1.500 risen by 13.21%
$1,107 Investor Webinar 7 May 2026 9:19AM $0.960 $1.500 risen by 56.25%
$1,107 QuarterlyActivities Report and Appendix 4C Cash Flow Report 30 Apr 2026 8:03AM $0.955 $1.500 risen by 57.07%
$1,107 EchoSolv AS deployed into Mount Sinai Health System 28 Apr 2026 8:36AM $1.145 $1.500 risen by 31%
$1,107 Becoming a substantial holder 10 Apr 2026 11:11AM $0.900 $1.500 risen by 66.67%
$1,107 Change of Director's Interest Notice x2 10 Apr 2026 11:07AM $0.895 $1.500 risen by 67.60%
$1,107 Cleansing Notice 10 Apr 2026 11:01AM $0.895 $1.500 risen by 67.60%
$1,107 Application for quotation of securities - EIQ 10 Apr 2026 10:59AM $0.895 $1.500 risen by 67.60%

1 - 25 of 377 results

Page 1 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.